Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures
- 30 November 1992
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 145 (1) , 199-209
- https://doi.org/10.1016/0008-8749(92)90323-h
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonistCytokine, 1991
- Reduced mitogen stimulation of DNA synthesis in human lymphocytes by a human recombinant interleukin-1 receptor antagonistImmunology Letters, 1991
- Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.Journal of Clinical Investigation, 1990
- Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4.Journal of Clinical Investigation, 1989
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- Monocytes and MacrophagesNew England Journal of Medicine, 1988
- Recombinant Interleukin 1 and Tumor Necrosis Factor Acting in Synergy to Release Thromboxane, 6-KETO-PGF1α, and PGEI2, by Human NeutrophilsScandinavian Journal of Rheumatology, 1988
- Multiple biological activities of human recombinant interleukin 1.Journal of Clinical Investigation, 1986
- Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures.The Journal of Experimental Medicine, 1983
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980